(Date:12/16/2009)... biotechnology company,s revenues increase 22% for fiscal 2009; ... 2010 , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix ... virology and biological technologies, today reported financial results ... fiscal year ended September 30, 2009, Microbix reported ... the same period in 2008. For fourth-quarter 2009, ...
(Date:12/16/2009)... cell culture supplement? InVitria has what scientists have been asking ... that improves the growth and productivity of CHO cells. Developed ... an animal free, well defined and consistent recombinant CHO supplement. ... ... December 16, 2009 -- Scientists working with CHO cells can ...
(Date:12/16/2009)... and Separations Society will hold its 23rd Annual Technical Conference & ... San Antonio, Texas. To further impact the separation society and reach ... to announce that the 2010 AFS Annual Technical Conference will be ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- The American ...
(Date:12/15/2009)... 15 Repligen Corporation (Nasdaq: RGEN ... $731,000 in research funding to support the ongoing ... the Muscular Dystrophy Association (MDA). This grant ... testing and GMP manufacture of a drug candidate ... MDA not only provides important funding for Repligen,s ...
Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3... -- WuXi PharmaTech (NYSE:,WX), China,s premier provider of pharmaceutical ... has promoted Mr. Edward Hu from Executive,Vice President of ... WuXi PharmaTech in August 2007, Mr. Hu was a ... a NASDAQ listed,company later acquired by Genentech, Inc. He ...
... Cambrex,Corporation (NYSE: CBM ) is pleased ... Chief Executive Officer, will make a presentation,on the ... 8, 2008 at,9:00 a.m. PST at the Westin ... http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), A live webcast of ...
... (Nasdaq: THOR ), a world leader in ... will be participating in the JP,Morgan Healthcare Conference ... and chief executive officer, will provide an,update on ... Time (11:30,a.m., Eastern Standard Time)., The presentation ...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO 2(Date:12/16/2009)... European Union (EU) member states ... which are increasingly subjected to unauthorised immigration ... advanced technology security and IT-based systems will ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, New analysis from ... Border Security Market Assessment - European Union ...
(Date:12/15/2009)... environmental impacts, social dynamics, and production levels are ... of an agroecosystem. Positive or negative, these factors ... social groups to continuously adapt farming and food ... learning theory suggests that knowledge is gained as ... are especially valuable for environmental and agricultural educators ...
(Date:12/15/2009)... found the fossil remains of a whale, 4.5 million years ... first time, the results of the decay and fossilisation process ... a baleen whale from the Mysticeti group. , This is ... a whale from the Lower Pliocene (five million years ago) ... first time that the results of the processes of fossilisation ...
Breaking Biology News(10 mins):Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3Experiential learning teaches change and adaptation 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3Blood test can detect brain damage in amateur boxers 54969 1Blood test can detect brain damage in amateur boxers 54969 2Switching on the power of stem cells 9639 1Switching on the power of stem cells 9639 2Nostrils alternate to process competing odors 9636 1Nostrils alternate to process competing odors 9636 2... a particularly aggressive form of skin cancer malignant ... hearing that diagnosis, might amplify the progression of their ... this also suggests that the use of commonly prescribed ... tumors and therefore improve these patients, quality of life. ...
... Jan. 29 Entrust, Inc. (Nasdaq: ENTU ), a ... results for its fiscal quarter and year ended December 31, 2008.Fourth-Quarter ... Total revenues of $24.9 million, a decrease of 7% over ... and were $27.9 million, an increase of 5%, adjusting for ...
... you,ve ever wondered why some allergic reactions progress quickly ... published in the February 2009 issue of the ... an important part of the answer. In the report, ... and Trinity College Dublin show for the first time ...
Other Biology News:Stress may hasten the growth of melanoma tumors 2Stress may hasten the growth of melanoma tumors 3Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 2Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 3Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 4Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 5Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 6Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 7Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 8Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 9Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 10Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 11Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 12Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 13Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 14Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 15Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 16Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 17Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 18Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 19Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 20Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 21New discovery may lead to new class of allergy drugs 2... of the human Topoisomerase II gene. ... state of nucleic acids by passing an intact ... a separate DNA helix (1,2) . As a ... enzyme can relax negatively or positively supercoiled DNA, ...
... Topo I, Wild Type Liquid. In ... DTT, 200 µM EDTA, 20% glycerol, pH 7.9. ... I) is a monomeric protein of 765 amino ... the relaxation of both positive and negative supercoiled ...
Request Info...
... RNA polymerase is a DNA-dependent RNA polymerase ... promoters. It efficiently synthesizes in vitro ... down stream from a T7 promoter. ... templates for in vitro translation, substrates in ...
Biology Products:Biology NavigationMedical Navigation